Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS
Status:
Recruiting
Trial end date:
2022-08-07
Target enrollment:
Participant gender:
Summary
This multi-center, open, randomized study will evaluate the efficacy and safety of BDB-001
injection in severe COVID-19 with severe pneumonia, or acute lung injury/acute respiratory
distress syndrome. Patients will be randomized to two treatment arms (Arm A: Conventional
treatment + BDB-001; Arm B: Conventional treatment alone).